STAT3 as a central mediator of neoplastic cellular transformation
- 28 November 2006
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 251 (2) , 199-210
- https://doi.org/10.1016/j.canlet.2006.10.017
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Cyclin D1 Overexpression and Response to Bortezomib Treatment in a Breast Cancer ModelJNCI Journal of the National Cancer Institute, 2006
- STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytesBlood, 2006
- Tyrosine Phosphorylation Is Required for Functional Activation of Disulfide-Containing Constitutively Active STAT MutantsBiochemistry, 2006
- Malignant Transformation but not Normal Cell Growth Depends on Signal Transducer and Activator of Transcription 3Cancer Research, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasisOncogene, 2004
- Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphomaBlood, 2003
- Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell TransformationJournal of Biological Chemistry, 2001
- The Hallmarks of CancerCell, 2000
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987